Page last updated: 2024-08-22

phenethyl isothiocyanate and bortezomib

phenethyl isothiocyanate has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baggio, R; El Oualid, F; Fasci, D; Hedstrom, L; Lawson, AP; Long, MJC; Qian, Y; Rozhansky, L; Weerapana, E1
Gartel, AL; Halasi, M; Hay, N; Nogueira, V; Pandit, B; Wang, M1

Other Studies

2 other study(ies) available for phenethyl isothiocyanate and bortezomib

ArticleYear
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
    Bioorganic & medicinal chemistry letters, 2019, 01-15, Volume: 29, Issue:2

    Topics: Carbonates; Deubiquitinating Enzymes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Ubiquitination

2019
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
    The American journal of pathology, 2013, Volume: 183, Issue:1

    Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Administration Schedule; Estradiol; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Humans; Isothiocyanates; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Oxidative Stress; Pyrazines; Random Allocation; Reactive Oxygen Species; RNA Interference; Transplantation, Heterologous; Treatment Outcome

2013